|
|
||||||||
Papers In Press, published online ahead of print August 13, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cell Biology and Anatomy, Medical University of South Carolina, Charleston, SC 29425
Corresponding Author: argravek{at}musc.edu
The lysosphingolipid, sphingosine 1-phosphate (S1P), is a component of high density lipoproteins (HDL). Findings from a growing number of studies indicate that S1P is a mediator of many of the cardiovascular effects of HDL including the ability to promote vasodilation, vasoconstriction, angiogenesis, protect against ischemia/reperfusion injury and inhibit/reverse atherosclerosis. These latter cardioprotective effects are being shown to involve S1P-mediated suppression of inflammatory processes including reduction of endothelial expression of monocyte and lymphocyte adhesion molecules, decreased recruitment of polymorphonuclear cells to sites of infarction as well as blocking of cardiomyocyte apoptosis following myocardial infarction. This review article summarizes the evidence that S1P as a component of HDL serves to regulate vascular cell and lymphocyte behaviors associated with cardiovascular (patho)physiology.
Revised on August 13, 2007
Accepted on August 13, 2007
HDL serves as an S1P signaling platform mediating a multitude of cardiovascular effects
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. M. Scanu and C. Edelstein HDL: bridging past and present with a look at the future FASEB J, December 1, 2008; 22(12): 4044 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Argraves, P. J. Gazzolo, E. M. Groh, B. A. Wilkerson, B. S. Matsuura, W. O. Twal, S. M. Hammad, and W. S. Argraves High Density Lipoprotein-associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function J. Biol. Chem., September 5, 2008; 283(36): 25074 - 25081. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pirillo, P. Uboldi, C. Bolego, H. Kuhn, and A. L. Catapano The 15-Lipoxygenase-Modified High Density Lipoproteins 3 Fail to Inhibit the TNF-{alpha}-Induced Inflammatory Response in Human Endothelial Cells J. Immunol., August 15, 2008; 181(4): 2821 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mallat and A. Tedgui HDL, PTX3, and Vascular Protection Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 809 - 811. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |